Stay updated with breaking news from New Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New Phase II data show evobrutinib sustained low annualized relapse rates (ARRs) and had no new safety signals at 2.5 years the longest follow-up of any Bruton's tyrosine kinase inhibitor in multiple
The selection of Jha underscores that the White House will do nothing to stop the pandemic as the Omicron BA.2 subvariant spreads uncontrolled, and all federal pandemic resources dry up.
The National Institute of Allergy and Infectious Diseases (NIAID) has launched Phase 1 clinical trial to evaluate experimental HIV vaccines.
